IPOPLUS

1,617.1

+17.2 +1.08%

17 Jun 2026

NSE Listed · Pharmaceuticals

Onesource Specl Pharma Limited (ONESOURCE)

Volume: 9,464Avg Vol 1W: 14,327Avg Vol 1M: 20,16752W Range:1,0572,248
₹1,617.1 1.08%
Market Cap₹18,497 Cr
Current Price₹1,617.1
Previous Close₹1,599.9
High / Low (52w)₹2,248 / ₹1,057
Volume9,464
Avg Vol (1W)14,327
Avg Vol (1M)20,167
Stock P/E
Book Value₹508.84
Dividend Yield0%
ROE-1.1%
ROA-0.9%
Revenue (TTM)
Revenue Growth7.4%
Profit Margin-5.19%
Total Debt₹219 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹0.4
P/B3.54
Debt / Equity0.26
50 DMA₹1,776.31
200 DMA₹1,526.69
Day change+1.08%
Price Chart
1,617.1 10.11% · 1Y
1921111045.3L
2025-10-01
2026-06-16

20-day avg volume: 19K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 730% YoY.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue₹428 Cr₹290 Cr₹376 Cr₹327 Cr₹426 Cr₹393 Cr₹334 Cr₹292 Cr₹73 Cr₹56 Cr₹34 Cr
EBITDA₹22 Cr₹-48 Cr₹40 Cr₹26 Cr₹117 Cr₹80 Cr₹13 Cr₹0 Cr₹-20 Cr₹-29 Cr₹-57 Cr
Net Profit₹5 Cr₹-89 Cr₹10 Cr₹0 Cr₹99 Cr₹-69 Cr₹-42 Cr₹-6 Cr₹-40 Cr₹-130 Cr₹-114 Cr
EPS0.4-7.740.91-0.028.59-6.31-10.13-0.51-9.67-31.32-27.37
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,462 Cr₹176 Cr₹41 Cr₹132 Cr₹22 Cr₹2 Cr
EBITDA₹210 Cr₹-160 Cr₹-224 Cr₹-53 Cr₹-105 Cr₹-112 Cr
Net Profit₹-18 Cr₹-391 Cr₹-800 Cr₹-231 Cr₹-121 Cr₹-140 Cr
EPS-1.63-94.15-200.87-65.25-66.65-1,891.41
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹7,550 Cr₹1,309 Cr₹2,009 Cr₹2,442 Cr₹1,258 Cr₹971 Cr
Total Liabilities₹1,670 Cr₹913 Cr₹1,223 Cr₹1,430 Cr₹482 Cr₹554 Cr
Equity₹5,881 Cr₹396 Cr₹785 Cr₹1,012 Cr₹776 Cr₹417 Cr
Total Debt₹219 Cr₹272 Cr₹335 Cr₹597 Cr₹309 Cr₹359 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-61 Cr₹-107 Cr₹-174 Cr₹-416 Cr₹-117 Cr₹-52 Cr
Investing₹-201 Cr₹511 Cr₹-68 Cr₹-692 Cr₹-207 Cr₹-157 Cr
Financing₹412 Cr₹-391 Cr₹118 Cr₹1,162 Cr₹381 Cr₹65 Cr
Free Cash Flow₹-189 Cr₹-171 Cr₹-218 Cr₹-1,071 Cr₹-117 Cr₹-52 Cr
Shareholding
Promoter 30.48% Institutions 38.11% Public 31.41%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search